[{"address1": "1180 Seminole Trail", "address2": "Suite 495", "city": "Charlottesville", "state": "VA", "zip": "22901", "country": "United States", "phone": "434 422 9800", "website": "https://www.adialpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 63, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 415076, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph A. M. Truluck M.B.A., MBA", "age": 45, "title": "CFO, Treasurer & Secretary", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": 279700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 59, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 59000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D.", "age": 63, "title": "Founder & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 375000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "General Counsel", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Lugovoy", "title": "Chief Business Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack W. Reich Ph.D.", "age": 74, "title": "Head of Regulatory", "yearBorn": 1949, "fiscalYear": 2022, "totalPay": 17006, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark H. Peikin", "title": "Chief Strategy Officer & Chief Development Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine  Fratila", "title": "Controller", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.12, "open": 2.07, "dayLow": 1.96, "dayHigh": 2.2, "regularMarketPreviousClose": 2.12, "regularMarketOpen": 2.07, "regularMarketDayLow": 1.96, "regularMarketDayHigh": 2.2, "beta": 1.524, "forwardPE": -1.4109589, "volume": 863206, "regularMarketVolume": 863206, "averageVolume": 3995780, "averageVolume10days": 22696960, "averageDailyVolume10Day": 22696960, "bid": 1.97, "ask": 2.12, "bidSize": 1000, "askSize": 1100, "marketCap": 3426645, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 14.0, "fiftyDayAverage": 1.4782, "twoHundredDayAverage": 3.37905, "currency": "USD", "enterpriseValue": 2193160, "floatShares": 972229, "sharesOutstanding": 1663420, "sharesShort": 173322, "sharesShortPriorMonth": 37202, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.1042, "heldPercentInsiders": 0.09802, "heldPercentInstitutions": 0.15911001, "shortRatio": 0.34, "shortPercentOfFloat": 0.1117, "impliedSharesOutstanding": 1663420, "bookValue": 1.921, "priceToBook": 1.0723581, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -9582406, "trailingEps": -8.98, "forwardEps": -1.46, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.216, "52WeekChange": -0.8083721, "SandP52WeekChange": 0.3288405, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ADIL", "underlyingSymbol": "ADIL", "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1532698200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a144d6a7-1775-3bb1-b1ca-599a0edca1eb", "messageBoardId": "finmb_112638788", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.06, "targetHighPrice": 26.0, "targetLowPrice": 8.0, "targetMeanPrice": 17.0, "targetMedianPrice": 17.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 315880, "totalCashPerShare": 0.259, "ebitda": -10150964, "quickRatio": 1.261, "currentRatio": 2.15, "returnOnAssets": -1.197, "returnOnEquity": -2.47342, "freeCashflow": -4632171, "operatingCashflow": -7335125, "financialCurrency": "USD", "trailingPegRatio": null}]